SparingVision
Developing an emerging therapy against the central vision loss generated by pigmentary retinopathies. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
AUD510—765m (Dealroom.co estimates Sep 2022.)
Company register number 821148327
Paris Île-de-France (HQ), Paris Île-de-France (founding location)
- hard tech
- biotechnology
- horizon europe
- biotech and pharma
- tech for business
- spinout
- eit ecosystem
- genetics
- dna
- observatoire deeptech
- eit health
- genome engineering
- biotech, medtech and e-health
- visualization
- participations bpifrance
- european health catapult (eit health)
- ophthalmology
- eye diseases
- european health catapult 2019 (eit health)
- injections
Authorizing premium user...